Using targeted radiation during surgery - referred to as intraoperative radiation - to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins ...

Using targeted radiation during surgery — referred to as intraoperative radiation — to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins ...

Using targeted radiation during surgery - referred to as intraoperative radiation - to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins ...

Out of the 16 patients in the study, half had a strong response to the vaccine. A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a ...

The pancreas is an organ behind the stomach and near the spleen. It performs both exocrine and endocrine functions. The exocrine cells release digestive enzymes to assist with breaking down food. The ...

Medically reviewed by David Strosberg, MD Key Takeaways Recovery after a Whipple procedure takes about six to eight weeks.You need to meet certain milestones before being discharged from the hospital ...

The vast majority of pancreatic cancer patients experience recurrence even after surgery. An experimental vaccine could change that, an early-phase study found. The vaccine is based on peptides, ...

Research shows that gastrointestinal cancers — including stomach, liver, esophageal, pancreatic, and colorectal cancers — account for about 26% of all cancers worldwide and 35% of all cancer-related ...

A new risk score can help predict whether a pancreatic cancer survivor will suffer a recurrence of cancer The 13-point risk score can help doctors more closely monitor patients at higher risk About 10 ...

More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...

The 13-point risk score can help doctors more closely monitor patients at higher risk About 10% of patients suffer a cancer recurrence, most often in their liver FRIDAY, Dec. 19, 2025 (HealthDay News) ...